Continuous Manufacturing in Pharmaceutical Powder Processing

Continuous manufacturing is gaining traction in the pharmaceutical industry, particularly in processes involving powders and bulk solids. For oral solid dosage forms, production often consists of interconnected unit operations such as milling, feeding, blending and compaction, which can be combined into a continuous process line. Rather than relying on batch-based scale-up, continuous manufacturing focuses on stable material flow, controlled process conditions and consistent product quality.

In powder-based pharmaceutical processes, the transition to continuous manufacturing depends on a deep understanding of both material properties and process behaviour. Factors such as particle size distribution, flowability, bulk density and segregation tendency directly affect process stability. As a result, continuous processing is typically approached from a process engineering perspective, where individual unit operations are designed to function as part of an integrated and controlled system.

Designing a Continuous Pharmaceutical Powder Process

Continuous pharmaceutical powder processing is rarely a matter of connecting individual machines in sequence. A stable continuous line depends on how material properties, feeding behaviour, residence time, mixing energy, compaction behaviour and containment requirements interact across the full process.

Hosokawa Micron supports pharmaceutical manufacturers in translating these process requirements into integrated powder processing systems, from material evaluation and equipment selection to testing and process configuration.

Milling and particle size control

In many pharmaceutical formulations, powders must first be conditioned to achieve the required particle size distribution. Technologies such as impact mills, jet mills and classifier mills are commonly used for this purpose.

Milling is inherently suitable for continuous operation and can be integrated into a process line. Control of particle size is critical, as it influences downstream properties such as flowability, blend uniformity and compressibility.

Feeding and dosing

Accurate and stable feeding is essential in continuous manufacturing. Both gravimetric and volumetric feeders are used to ensure consistent mass flow into the process. Variations in feed rate can directly affect residence time, blend composition and final product quality. This makes feeder selection and calibration a key aspect of process design, especially when handling cohesive or low-dose materials.

Continuous blending

Blending of APIs and excipients is one of the most critical steps in pharmaceutical powder processing. Continuous blending systems are designed to deliver uniform mixtures while maintaining short residence times and minimal material hold-up.

This is particularly important for formulations with:

• low API concentrations
• poor-flowing powders
• sensitivity to over-processing

Proper control of blending conditions helps prevent segregation and ensures consistent content uniformity.

Lubricant addition

In many formulations, lubricants such as magnesium stearate are added prior to tableting. This step requires careful control, as excessive mixing can negatively affect tablet properties, while insufficient mixing can lead to inhomogeneity. Continuous processes allow for controlled and reproducible lubricant distribution when process parameters are properly tuned.

Roller compaction and dry granulation

When powders exhibit poor flow or segregation tendencies, a densification step may be required. Roller compaction is commonly used in continuous lines to improve bulk density and handling characteristics.

After compaction, the material is typically milled to achieve the desired particle size for downstream processing. This step can improve flowability and reduce variability in the tableting process.

Process control: QbD and PAT

Continuous pharmaceutical manufacturing is closely linked to Quality by Design (QbD) and Process Analytical Technology (PAT). These frameworks emphasise understanding the relationship between material attributes, process parameters and product quality.

In powder processing, this may involve monitoring:

• particle size distribution
• blend uniformity
• feed rate stability
• residence time distribution

Techniques such as NIR spectroscopy can be used to assess blend homogeneity in real time, enabling faster process adjustments and improved quality assurance.

Containment and safe handling

Pharmaceutical powders often require strict containment, especially when dealing with potent or hazardous substances. Continuous manufacturing systems must therefore integrate containment solutions across all process steps, including feeding, milling, blending and transfer.

Effective containment ensures:

• operator safety
• product protection
• compliance with regulatory standards

Integration of continuous powder processing systems

The effectiveness of continuous manufacturing depends on how well individual unit operations are integrated. Rather than optimising each step separately, the focus is on the interaction between process stages and the stability of the overall system.

An integrated approach considers:

• material flow between units
• residence time distribution
• response to process disturbances
• scalability through time rather than batch size

This system-level perspective is essential for achieving consistent performance in pharmaceutical powder processing.

Continuous manufacturing offers a promising approach for pharmaceutical powder processing, particularly for solid dosage forms. By integrating unit operations such as milling, feeding, blending and compaction into a single process line, manufacturers can achieve improved efficiency, consistency and process understanding.

The successful implementation of continuous manufacturing depends on a thorough understanding of powder behaviour and a process-oriented approach to system design. As technologies and regulatory frameworks continue to evolve, continuous processing is expected to play an increasingly important role in pharmaceutical production.

Explore our powder processing technologies.